Healthcare resource utilization and costs before and after long-acting injectable antipsychotic initiation in commercially insured young adults with schizophrenia

BACKGROUND: Long-acting injectable (LAI) antipsychotics use is associated with improved adherence which can reduce the rate of relapse, hospitalization, and associated costs in patients with schizophrenia. Young adults could be at higher risk of poor adherence, hence use of LAI in this population ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Alex Z., Pesa, Jacqueline A., Lakey, Susan, Benson, Carmela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994268/
https://www.ncbi.nlm.nih.gov/pubmed/35395757
http://dx.doi.org/10.1186/s12888-022-03895-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994268/
https://www.ncbi.nlm.nih.gov/pubmed/35395757
http://dx.doi.org/10.1186/s12888-022-03895-2

Ejemplares similares